• Alida home
1 2 3 4

recent news

Medannex logo

Edinburgh
February 2018

Dr Tina Flatau will deliver a showcase presentation on Medannex, as part of BIA’s networking event at BioCity, Glasgow on Thursday 1 March. Free to attend. More info: https://tinyurl.com/ydcwc9ub

NuCana Logo

Edinburgh
January 2018

NuCana Announces Promising Clinical Data at ASCO GI on NUC-1031 (Acelarin®) as Front-line Treatment of Advanced Biliary Tract Cancer

aTen logo

Edinburgh
January 2018

Dr Fiona Dempsey (Director of Scientific Operations, aTen Therapeutics) joined Rose Maciewicz from AstraZeneca to address Glasgow University postdocs about industry career

NuCana Logo

Edinburgh
November 2017

NuCana Announces First Patients Enrolled in Phase 2 Study of Acelarin in Platinum-Resistant Ovarian Cancer

Welcome to Alida Capital International

Alida Capital International (ACI) is a prominent Scottish business angel syndicate focused on investing in Scotland's life sciences sector, specifically biotech and pharmaceutical companies.

ACI members have considerable entrepreneurial, financial and management experience in the biopharmaceutical sector, and offer a flexible approach to funding.

Since 2009, ACI with its syndicate partners has invested over £15 million into Scottish life science companies. One of the ACI investment companies, NuCana BioMed, was awarded the prestigious Scottish Enterprise Life Sciences Investment of the Year Award in 2013.

Selective and focused, ACI provides resources for talented entrepreneurs looking to transform the biotechnology and pharmaceutical industry.